Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Open-market buy Director bought 20,000 shares at $2.88 ($57,600)
  2. 4 Open-market buy President and CEO bought 20,000 shares at an average $2.85 ($57,009)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award Director acquired 16,806 shares (grant or award)
  5. 4 Grant or award Director acquired 16,806 shares (grant or award)
  6. 4 Grant or award Director acquired 4,201 shares (grant or award)
  7. 4 Grant or award Director acquired 8,403 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 5 Insider Annual Insider Trading Report
  17. 5 Insider Annual Insider Trading Report
  18. 4 Open-market sale Sr. VP, Pgm Mgmt and Clin Ops sold 4,573 shares at $6.20 ($28,375)
  19. 4 Open-market sale VP, Fin. and Admin., CFO sold 5,600 shares at $6.18 ($34,619)
  20. 4 Open-market sale VP, IP and Legal, Gen. Counsel sold 5,000 shares at $6.18 ($30,888)

Page 25 of 29 · 564 filings